Clinical Trial Update: Cobimetinib In Extracranial Arteriovenous Malformations (COBI-AVM Study) [Phase 2]

View source ↗

Summary

The COBI-AVM Phase 2 trial evaluating cobimetinib for extracranial arteriovenous malformations has completed enrollment. The study is sponsored by the Universit…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Arteriovenous Malformation

Drugs mentioned

• Cotellic (cobimetinib)

Snippet

Sponsor: University of Arkansas | Conditions: Arteriovenous Malformations (Extracranial) | Phase 2 | Status: COMPLETED